Advertisement
Screener

NovoCure Limited (NVCR) Interest Expense

NovoCure Limited Interest Expense

NovoCure Limited (NVCR) reported Interest Expense of $22.22 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2026-02-26

  • NovoCure Limited interest expense for fiscal 2025 was $22.22M, a 90.49% increase from fiscal 2024.
  • NovoCure Limited interest expense for fiscal 2024 was $11.66M, a 137.73% increase from fiscal 2023.
  • NovoCure Limited interest expense for fiscal 2023 was $4.91M, a 39.53% decline from fiscal 2022.
  • NovoCure Limited interest expense for fiscal 2022 was $8.11M, a 8.21% decline from fiscal 2021.
Period endInterest Expense 12 month
2025-12-31$22.22M
10-K · filed 2026-02-26
2024-12-31$11.66M
10-K · filed 2026-02-26
2023-12-31$4.91M
10-K · filed 2026-02-26
2022-12-31$8.11M
10-K · filed 2025-02-27
2021-12-31$8.84M
10-K · filed 2024-02-22
2020-12-31$18.05M
10-K · filed 2023-02-23
2019-12-31$14.64M
10-K · filed 2022-02-24
2018-12-31$16.91M
10-K · filed 2021-02-25
2017-12-31$11.69M
10-K · filed 2020-02-27
2016-12-31$7.32M
10-K · filed 2019-02-28
2015-12-31$3.23M
10-K · filed 2018-02-22
2014-12-31$287.00K
10-K · filed 2017-02-23
2013-12-31$12.82M
10-K · filed 2016-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77